| P2093 | author name string | Jin Chen | |
| | Lianming Liao | |
| | Jinquan Cai | |
| | Jianming Tan | |
| | Junqi Guo | |
| | Lianghu Huang | |
| | Shunliang Yang | |
| | Zhixian Wu | |
| P2860 | cites work | Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure | Q77890338 |
| | Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival | Q81255020 |
| | Lessons learned from more than 1,000 pancreas transplants at a single institution | Q24541751 |
| | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
| | Five-year follow-up after clinical islet transplantation | Q33218078 |
| | Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study | Q33342242 |
| | Alemtuzumab (Campath-1H): a systematic review in organ transplantation | Q36491577 |
| | The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation | Q36570565 |
| | Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions | Q36910477 |
| | Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. | Q40481568 |
| | The use of Campath-1H as induction therapy in renal transplantation: preliminary results | Q40488820 |
| | Insulin independence after islet transplantation into type I diabetic patient | Q41195322 |
| | Automated method for isolation of human pancreatic islets | Q42516583 |
| | Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients | Q43811347 |
| | Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results | Q43834374 |
| | Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft | Q43886598 |
| | Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases | Q44071218 |
| | Consequences on beta-cell function and reserve after long-term pancreas transplantation | Q44779243 |
| | Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up | Q44935467 |
| | Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus | Q45234379 |
| | Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation | Q46478191 |
| | Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results | Q46702767 |
| | Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation | Q46740554 |
| | Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression | Q46816120 |
| | Standards of medical care for patients with diabetes mellitus. American Diabetes Association | Q72179968 |
| | Consensus guidelines for the management of insulin-dependent (type 1) diabetes. European IDDM Policy Group 1993 | Q72769754 |
| | Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group | Q74038855 |
| | Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation | Q74650707 |
| | The use of antibodies against the IL-2 receptor in transplantation | Q77485579 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| | kidney transplantation | Q740909 |
| | kidney disease | Q1054718 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 2666-2671 | |
| P577 | publication date | 2008-07-15 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction | |
| P478 | volume | 57 | |